- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07566832
Velocity-Based Resistance Training Effects on Inflammation in Older Adults
2026년 5월 4일 업데이트: National Taipei University
Dose-Response Effects of Velocity-Based Resistance Training on Anti-Inflammatory Responses in Older Adults
This study aims to investigate the effects of resistance training (RT) with different training volumes on immune modulation and anti-inflammatory responses in older adults.
Participants will be randomly assigned to one of three RT volume groups (low, medium, or high) or a non-exercise control group.
Participants in the training groups will complete a 4-week RT program, followed by a 4-week detraining phase.
The findings are expected to provide evidence for volume-specific RT prescriptions to support healthy aging.
연구 개요
연구 유형
중재적
등록 (추정된)
60
단계
- 해당 없음
연락처 및 위치
이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.
연구 연락처
- 이름: Shun-Hsi Tsai, Ph.D.
- 전화번호: 68523 +88686741111
- 이메일: shunhsi@mail.ntpu.edu.tw
연구 장소
-
-
-
Taipei, 대만, 116
- 모병
- National Taiwan Normal University
-
연락하다:
- Hung-Wen Liu, Ph.D.
- 전화번호: +88677496863
- 이메일: hwliu@ntnu.edu.tw
-
연락하다:
- Kuan-Tsen Yeh, M.S.
- 전화번호: +886932815383
- 이메일: mickyyehyeh@gmail.com
-
-
참여기준
연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
예
설명
Inclusion Criteria:
- Aged 60-75 years or older
- No regular resistance training habit (defined as ≥2 sessions per week) in the past year
- No musculoskeletal injuries within the past six months
Exclusion Criteria:
- Obesity (BMI > 30 kg/m²), diabetes, hypertension, cancer, heart, kidney, or liver disease, or any other condition that may influence study outcomes.
- Regular use of anti-inflammatory medications (e.g., NSAIDs).
- Smoking or alcohol abuse
- Inability to safely perform the prescribed resistance exercise movements
- Unable to fully comprehend the study information and instructions.
공부 계획
이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 크로스오버 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: low training volume resistance exercise
Participants assigned to the low-volume resistance training group will perform one set per exercise at a load corresponding to 80% of 1RM.
Each set will be terminated when movement velocity decreases by 30% from the first repetition.
Rest intervals of 2-3 minutes will be provided between exercises.
|
The RT program will consist of 12 sessions over a 4-week period, with participants training three times per week and at least one rest day between sessions.
All sessions will be supervised by research personnel to ensure proper technique and safety.
Exercises will be performed using resistance machines and will include chest press, shoulder press, seated row, lat pulldown, and leg press.
|
|
실험적: medium training volume resistance exercise
Participants assigned to the medium-volume resistance training group will perform three sets per exercise at 80% of 1RM.
Each set will be terminated when movement velocity decreases by 30% relative to the first repetition.
Rest intervals of 90 seconds will be provided between sets, and 2-3 minutes between exercises.
|
The RT program will consist of 12 sessions over a 4-week period, with participants training three times per week and at least one rest day between sessions.
All sessions will be supervised by research personnel to ensure proper technique and safety.
Exercises will be performed using resistance machines and will include chest press, shoulder press, seated row, lat pulldown, and leg press.
|
|
실험적: high training volume resistance exercise
Participants assigned to the high-volume resistance training group will perform five sets per exercise at 80% of 1RM.
Each set will be terminated when movement velocity decreases by 30% relative to the first repetition.
Rest intervals of 90 seconds will be provided between sets, and 2-3 minutes between exercises.
|
The RT program will consist of 12 sessions over a 4-week period, with participants training three times per week and at least one rest day between sessions.
All sessions will be supervised by research personnel to ensure proper technique and safety.
Exercises will be performed using resistance machines and will include chest press, shoulder press, seated row, lat pulldown, and leg press.
|
|
간섭 없음: sedentary control
Participants in control trial stayed sedentary during the period.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Changes in IL-6 concentration
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Plasma IL-6 concentrations will be measured and reported in pg/mL.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in soluble IL-6 receptor concentration
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Soluble IL-6 receptor concentrations will be measured and reported in ng/mL.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in soluble gp130 concentration
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Soluble gp130 concentrations will be measured and reported in ng/mL.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in IL-10 concentration
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
IL-10 concentrations will be measured and reported in pg/mL.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in IL-1RA concentration
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
IL-1RA concentrations will be measured and reported in pg/mL.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in TNF-α concentration
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
TNF-α concentrations will be measured and reported in pg/mL.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Borgs Ratings of Perceived Exertion (RPE)
기간: 1-hour during each exercise intervention
|
Borgs RPE is a method of estimating exertion rating, based on a 1 to 10 rating scale (1 being the no exertion at all, 10 being maximal exertion).
|
1-hour during each exercise intervention
|
|
Handgrip strength
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Maximal handgrip strength will be assessed using a digital hand dynamometer and reported in kilograms.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Knee extension strength
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Maximal voluntary isometric and isokinetic concentric knee extension strength of the dominant leg will be assessed using an isokinetic dynamometer and reported in Newton-meters.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
30-second chair-stand test
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Lower-body functional capacity will be assessed by the number of repetitions completed during a 30-second chair-stand test.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Single-leg balance test
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Balance performance will be assessed as the duration of single-leg stance and reported in seconds.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Timed up and go test
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Functional mobility will be assessed using the Timed Up and Go test, with performance quantified as the time (seconds) required to stand up from a seated position, walk 3 meters, turn, walk back, and sit down.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in SHIP1 protein expression in peripheral blood mononuclear cells (PBMCs)
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Intracellular SHIP1 protein expression in PBMCs will be measured and reported in arbitrary units.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in gp130 (CD130) protein expression in PBMCs
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Intracellular gp130 (CD130) protein expression in PBMCs will be measured and reported in arbitrary units.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in STAT3 protein expression in PBMCs
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Intracellular STAT3 protein expression in PBMCs will be measured and reported in arbitrary units.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in phosphorylated STAT3 protein expression in PBMCs
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Intracellular phosphorylated STAT3 (p-STAT3) protein expression in PBMCs will be measured and reported in arbitrary units.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in IL-6 receptor alpha (CD126) protein expression in PBMCs
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Intracellular IL-6 receptor alpha (CD126) protein expression in PBMCs will be measured and reported in arbitrary units.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in Beta-2 adrenergic receptor (β2-AR) protein expression in PBMCs
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Intracellular β2-adrenergic receptor (β2-AR) protein expression in PBMCs will be measured and reported in arbitrary units.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in SOCS3 protein expression in PBMCs
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Intracellular SOCS3 protein expression in PBMCs will be measured and reported in arbitrary units.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in white blood cell count
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Total white blood cell count will be measured and reported in cells/μL.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in lymphocyte count
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Lymphocyte count will be measured and reported in cells/μL.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in neutrophil count
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Neutrophil count will be measured and reported in cells/μL.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Changes in monocyte count
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Monocyte count will be measured and reported in cells/μL.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Body fat percentage
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Body fat percentage will be measured using a body composition analyzer and reported as a percentage.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
|
Lean body mass
기간: Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
Total lean body mass will be measured using a body composition analyzer and reported in kilograms.
|
Baseline, post-intervention (4 weeks), and at 2 and 4 weeks during detraining
|
공동 작업자 및 조사자
여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.
수사관
- 수석 연구원: Shun-Hsi Tsai, Ph.D., National Taipei University
연구 기록 날짜
이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.
연구 주요 날짜
연구 시작 (실제)
2026년 4월 20일
기본 완료 (추정된)
2029년 3월 1일
연구 완료 (추정된)
2029년 12월 1일
연구 등록 날짜
최초 제출
2026년 4월 15일
QC 기준을 충족하는 최초 제출
2026년 4월 28일
처음 게시됨 (실제)
2026년 5월 5일
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
2026년 5월 8일
QC 기준을 충족하는 마지막 업데이트 제출
2026년 5월 4일
마지막으로 확인됨
2026년 4월 1일
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- ECKIRB1140803
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
아니요
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
아니
미국 FDA 규제 기기 제품 연구
아니
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Resistance exercise에 대한 임상 시험
-
University of TorontoUniversity Health Network, Toronto; University of Western Ontario, Canada; Institute for... 그리고 다른 협력자들완전한
-
Federal University of Health Science of Porto Alegre완전한
-
Cukurova University완전한
-
The Hong Kong Polytechnic University완전한
-
University of Maryland, BaltimoreNational Institute on Aging (NIA)완전한